IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

AH Equity Partners Bio II, L.L.C.

Q1 2022 Holdings

Filed 2022-05-16 | 4 holdings | $173.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
EQRx, Inc.Common Stock26886C107$72.0K17,438,46541.5%
Nautilus Biotechnology, Inc.(NAUT)Common Stock63909J108$70.7K16,298,00640.7%
Erasca, Inc.(ERAS)Common Stock29479A108$21.5K2,500,00012.4%
InVitae Corporation(NVTA1EUR)Common Stock46185L103$9.3K1,170,1275.4%